CRP and cancer: In light of mechanistic insights into the association between reduced ApoA1 and the increased risk of cancer mortality, a significant inverse correlation between the extent of chronic systemic inflammation represented by hs‐CRP level and ApoA1 might be a possible explanation in our study.